|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
10 months to Dec 31, 2022
|
|
|---|---|---|---|---|
| Revenues, net | ||||
| Related Party | ||||
| Nonrelated Party | ||||
| Total revenues, net | ||||
| Cost of revenues (including cost of revenues from related parties of $13,657,565 and $8,472,202 for the years ended December 31, 2025 and 2024, respectively) | ||||
| Related Party | ||||
| Total cost of revenues (including cost of revenues from related parties of $13,657,565 and $8,472,202 for the years ended December 31, 2025 and 2024, respectively) | ||||
| Gross profit | ||||
| Operating expenses: | ||||
| Selling, general and administrative expenses (including selling, general and administrative expenses from related parties of $751,096 and nil for the years ended December 31, 2025 and 2024, respectively) | ||||
| Stock-based compensation | ||||
| Misappropriation loss | ||||
| Impairment loss on intangible asset | ||||
| Related Party | ||||
| Total operating expenses | ||||
| Franchise tax expense | ||||
| Income from operations | ||||
| Other income (expenses): | ||||
| Interest and dividend income on investments held in Trust Account | ||||
| Interest income | ||||
| Interest expense | ||||
| Foreign currency exchange gain, net | ||||
| Other income (including other income from related parties of $3,069 and $2,673,077 for the years ended December 31, 2025 and 2024, respectively) | ||||
| Related Party | ||||
| Total other income (including other income from related parties of $3,069 and $2,673,077 for the years ended December 31, 2025 and 2024, respectively) | ||||
| Other expenses | ||||
| Gain on redemption of life insurance policies | ||||
| Gain on disposal of subsidiary | ||||
| Total other income | ||||
| Income before income taxes | ||||
| Effective tax rate | ||||
| Net income | ||||
| Less: net income attributable to non-controlling interests | ||||
| Net income attributable to SBC Medical Group Holdings Incorporated | ||||
| Total net income attributable to SBC Medical Group Holdings Incorporated | ||||
| Other comprehensive loss: | ||||
| Foreign currency translation adjustment | ||||
| Reclassification of unrealized gain on available-for-sale debt security to net income when realized, net of tax effect of nil and $3,869 for the years ended December 31, 2024 and 2023, respectively | ||||
| Total comprehensive income | ||||
| Less: comprehensive income attributable to non-controlling interests | ||||
| Comprehensive income attributable to SBC Medical Group Holdings Incorporated | ||||
| Net income per share attributable to SBC Medical Group Holdings Incorporated* | ||||
| Net income per share attributable to SBC Medical Group Holdings Incorporated - Basic | ||||
| Common Class A | ||||
| Common Class B | ||||
| Total net income per share attributable to SBC Medical Group Holdings Incorporated - Basic | ||||
| Net income per share attributable to SBC Medical Group Holdings Incorporated - Diluted | ||||
| Common Class A | ||||
| Common Class B | ||||
| Total net income per share attributable to SBC Medical Group Holdings Incorporated - Diluted | ||||
| Weighted average shares outstanding* | ||||
| Weighted average shares outstanding - Basic | ||||
| Common Class A | ||||
| Common Class B | ||||
| Total weighted average shares outstanding - Basic | ||||
| Weighted average shares outstanding - Diluted | ||||
| Common Class A | ||||
| Common Class B | ||||
| Total weighted average shares outstanding - Diluted | ||||
Loading...